Jiu'an Medical has acquired overseas companies for the labeling of international labels
Andon Health June 28 Andon Health released a major asset purchase report, for the acquisition of foreign assets by Andon Health intends to non-public offering fund-raising not more than 710 million yuan to add the acquisition costs. Purchase 100% equity of eDevice by paying cash. Jiu'an Medical intends to raise no more than 710 million yuan from issuing shares to no more than 10 specific targets on the first day of the issue date, and use the net proceeds of 699 million yuan for the acquisition of Mark Bellerby and Stephen Shen. Nazi and other 17 counterparties collectively hold a 100% stake in eDevice, and a 100% stake in eDevice is priced at 93,884,300 euros. The exchange rate of 1 euro to 7.4434 yuan on June 26, 2016 (the June 26, 2016), the purchase price was 699 million yuan. Based on December 31, 2015 as the benchmark date, the value of the total equity of eDevice shareholders was assessed by the income method with a result of RMB 948.67 million and a value-added rate of 664.55%. Jiu'an Medical continues to carry out cooperation with all levels of medical service organizations in Europe, the United States, and the United States, based on the strategy of “wearing devices and smart hardware as the entrance to mobile medical and health big data, and then building a healthy ecosystem around usersâ€. China provides telemedicine products and telemedicine management solutions for medical service providers, providing services and data collection methods for patients with terminal diseases. In this acquisition, Jiu'an Medical will be further optimized from the overall product, business system and market layout, and synergies will appear in the future. According to relevant information, the acquired eDevice is a leading international provider of medical equipment data information system solutions. In his early years, he focused on the development of IoT products, and in 2008 began to specialize in the field of mobile medical care that is widely optimistic. eDevice's main products and services include mobile medical communication equipment production and sales, remote communication services and remote monitoring and management platform. The target company has become the leader in the M2M (Machine-to Machine) communication service in the medical and health industry. Due to the early entry into the Internet of Things, eDevice has accumulated a lot of industry experience, which has formed a great first-mover advantage in this field. Xi'an XJeson Biotech Co., Ltd , https://www.xjesonbio.com